| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $203K | -85.1% |
| Cost of Revenue | $38K | -75.6% |
| Gross Profit | $165K | -86.3% |
| R&D Expense | $95K | +55.7% |
| SG&A Expense | $1.1M | +49.3% |
| Operating Income | -$987K | -325.3% |
| Interest Expense | $6K | +700.0% |
| Net Income | -$113K | -125.7% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249K | +39.1% |
| Accounts Receivable | $10K | — |
| Current Assets | $286K | +46.7% |
| Total Assets | $297K | +19.8% |
| Current Liabilities | $102K | -82.9% |
| Long-term Debt | $135K | -2.9% |
| Total Liabilities | $228K | -68.7% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$806K | -568.6% |
| Investing Cash Flow | $880K | — |
| Financing Cash Flow | -$4K | +63.6% |
| — |
| EPS (Diluted) | $0.00 | — |
| Stockholders' Equity |
| $69K |
| +114.4% |